Outsourcing

Feb 01, 2018
Pharmaceutical Technology
Research suggests that working with a single contract partner can reduce development time and improve economics.
Feb 01, 2018
Pharmaceutical Technology
This article describes how to improve the regulatory journey from classification to market clearance for sponsors of medical device combination products.
Feb 01, 2018
Pharmaceutical Technology
CRLs put the brakes on drug development and damage corporate reputation and stock prices. Upfront investment and better sponsor oversight are ways to prevent them.
Feb 01, 2018
Pharmaceutical Technology
Successful outsourcing relationships in early phase drug-development analytics are driven by partnership.
Feb 01, 2018
Pharmaceutical Technology
A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.
Feb 01, 2018
Pharmaceutical Technology
Chemical engineers and chemists each bring unique skills to API process development and optimization. Success depends on their close collaboration, at both sponsor and CDMO facilities.
Feb 01, 2018
By Pharmaceutical Technology Editors
Biopharm industry veteran Ralf Otto named to lead development and manufacturing at Rentschler Biopharma.
Feb 01, 2018
By Pharmaceutical Technology Editors
Avista Pharma's strengthens early phase drug development offerings with acquisition of Solid Form Solutions.
Feb 01, 2018
By Pharmaceutical Technology Editors
Cambrex invests in development and laboratory facilities and adds staff.
Jan 26, 2018
By Pharmaceutical Technology Editors
The contract development and manufacturing organization has invested £30-million (US$42 million) at its Dundalk, Ireland site to offer expanded clinical trial services.
native1_300x100
lorem ipsum